Editorial Team
Editors-in-Chief
Shukui Qin, MD, PhD
Chair of Chinese Society of Clinical Oncology (CSCO); Deputy Director of People’s Liberation Army (PLA) 81 Hospital (Nanjing, China); Director of Cancer Center of Chinese PLA, China.
Jiade J. Lu, MD, MBA
China National Distinguished Expert; Executive Vice President, Shanghai Proton and Heavy Ion Center (SPHIC); Professor of Clinical Oncology, Fudan University School of Medicine, China
Charles M. Balch, MD, FACS
Professor of Surgery, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Associate Editors-in-Chief
Ghassan Abou-Alfa, MD, MBA (Liver Cancer)
Memorial Sloan Kettering Cancer Center, Weill Medical College at Cornell University, New York, USA.
Eileen M. O'Reilly, MD (Pancreatic Cancer)
David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA
Wenyin Shi, MD, PhD
Department of Radiation Oncology, Thomas Jefferson University; Jefferson Brain Tumor Center; Jefferson Cutaneous Lymphoma Center, Philadelphia, Pennsylvania, USA
Andrew X. Zhu
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
Associate Editor
Daniel G. Haller, MD, FACP, FASCO, FRCP (Gastrointestinal Cancer)
Abramson Cancer Center at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Statistical Editor
Binhuan Wang, PhD
Division of Biostatistics, Department of Population Health, New York University, New York, New York, USA
Editorial Board (Breast Oncology)
Shaheenah Dawood
Department of Medical Oncology, Mediclinic City Hospital, Comprehensive Cancer Center, Dubai Health Care City, Dubai, U.A.E
Joseph Gligorov
Breast Cancer Expert Center, APHP Tenon, IUC-UPMC Sorbonne University, Paris, France
Gabriel N. Hortobagyi
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Virginia Kaklamani, MD, DSc
Division Hematology/Oncology, Northwestern University, Chicago, Illinois, USA
Suzanne Klimberg, MD, PhD, FACS
Cancer Institute, University of Texas Medical Branch at Galveston, Galveston, TX, USA
Heriberto Medina-Franco, MD, FACS
Division of Surgery. Section of Surgical Oncology. National Institute of Medical Sciences and Nutrition, Mexico City, Mexico
Francesco Ricci
Institute Curie, PSL Research University, Department of Medical Oncology, Paris, France
Hope S. Rugo, MD
Breast Oncology and Clinical Trials Education, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA
Priyanka Sharma
University of Kansas Medical Center, Westwood KS 66205, USA
Yutaka Yamamoto, MD, PhD
Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
Editorial Board (Hematological Oncology)
Onder Alpdogan
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
Rupert Handgretinger, MD
Children’s University Hospital, Department Hematology/Oncology, University of Tuebingen, Hoppe-Seyler-Strasse 1, 72076 Tuebingen, Germany
Bhumsuk Keam MD, PhD
Seoul National University Hospital, Korea
Grzegorz S. Nowakowski
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Editorial Board (Gastrointestinal Oncology)
Tomoyuki Abe
Department of Surgery, Onomichi General Hospital, Japan
Hana Alguel, MD, MPH
Technical University of Munich, Munich, Germany
Suhad M. Bahijri, BSc, PhD, FICN
Professor of Clinical Biochemistry and Nutrition, Department of Clinical Biochemistry, Head of Saudi Diabetes Research Group, Faculty of Medicine & King Fahd Medical Research Centre, King Abdulaziz University, Jeddah Saudi Arabia
Tanios Bekaii-Saab, MD, FACP
Medical Director, Cancer Clinical Research Office, Section Chief and Vice-Chair, Division of Hematology/Oncology, Consultant, Mayo Clinic, Phoenix, Arizona, USA
Cédric Coulouarn, PhD
Inserm UMR-1242, "Chemistry, Oncogenesis, stress, Signaling" (COSS), University of Rennes 1, Comprehensive Cancer Center Eugène Marquis, Rennes, France
Savio George Alberto da Piedade Barreto, MS, FRACS, PhD
Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia
Matteo Donadon, MD, PhD
Assistant Professor of Surgery, Department of Hepatobiliary & General Surgery, Humanitas, University, Humanitas Clinical and Research Center – IRCCS, Via Manzoni 56, 20089, Rozzano, Milan, Italy
Traian Dumitrascu, MD, PhD
Department of General Surgery and Liver
Transplantation, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Fundeni Street no 258, 022328 Bucharest, Romania
Andrew S. Epstein, MD
Gastrointestinal Oncology Service, Palliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA
Antonio Giorgio
Liver Unit and Interventional Ultrasound Unit , Athena Clinical Institute, Piedimonte Matese (CE), Italy
Francesco Giudici, MD, PhD
Careggi University Hospital of Florence, Italy
Axel Grothey, MD
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
Ho-Seong Han, MD, PhD
Professor of Department of Surgery, Seoul National University Bundang Hospital, Seoul National University, College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea
Jin He, MD, PhD (Pancreatic Surgery)
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
David Ilson, MD, PhD
Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Hiromichi Ito, MD
Division of Hepatobiliary and Pancreatic Surgery, Japanse Foundation for Cancer Research, Cancer Insitute Hospital, Japan
Long R Jiao, MD, FRCS
Hepato-Pancreato-Biliary (HPB) Surgical Unit, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK
Elio Jovine, MD, FACS
Full Professor of Surgery, Department of General Surgery, University of Bologna Alma Mater Studiorum, Bologna, Italy
Tatsuo Kanda, MD, PhD
Associate Professor of Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan
Matthew H. G. Katz, MD
Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA
David J Kerr, MA, MD, DSc, FRCP (Glas, Lon & Edin), FRCGP (Hon)
Co-Director, Oxford-Sichuan Gastrointestinal Cancer Centre
Nuffield Dept Clinical and Laboratory Sciences, University of Oxford, Weill-Cornell College of Medicine, New York, USA
Yoji Kishi, MD, PhD
Department of Surgery, National Defense Medical College, Saitama, Japan
Geoffrey Ku, MD
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
Eric C.H. Lai, FRACS
Consultant, Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China
Giovanni Battista Levi Sandri, MD, PhD
Department of General Surgery and Transplantation, San Camillo Forlanini Hospital, Rome, Italy
Nikolaos Machairas, MD, PhD
2nd Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Greece
Bruce D. Minsky, MD
Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA
Yoshihiro Mise, MD, PhD
Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Hospital, Tokyo, Japan
Luca Morelli, MD, FACS, FASCRS
General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy
Yi-Qian Nancy You, MD, MHSc, FACS
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Duilio Pagano, MD
Abdominal Transplantation Surgery, ISMETT-IRCCS UPMC, Italy
David P. Ryan, MD
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA
Kazunari Sasaki, MD
Department of general Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA
Mark A. Schattner MD, FASGE, ASGF
Department of Medicine, Gastroenterology, Hepatology, and Nutrition Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Junichi Shindoh, MD, PhD
Surgeon-in-chief, Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan
Kjetil Søreide, MD, PhD, FRCS (Edin), FACS
Consultant general and HPB surgeon, Department of Gastrointestinal Surgery, Stavanger University Hospital, Norway
Professor of Surgery, Department of Clinical Medicine, University of Bergen, Norway
Lead, Gastrointestinal Translational Research Unit, Laboratory for Molecular biology, Stavanger University Hospital, Norway
Cosimo Sperti, MD
Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
Alessandro Vitale, MD, PhD
Unità di Chirurgia Epatobiliare e dei Trapianti Epatici, Azienda Ospedale Università di Padova, Italy
Norman Wolmark, MD
Chairman of the NSABP Foundation, Co-Chair of NRG Oncology, and Medical Director of Allegheny Health Network (AHN) Cancer Institute Research, Pittsburgh, Pennsylvania, USA
Adam C. Yopp
Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, USA
Editorial Board (Head and Neck Oncology)
N Gopalakrishna Iyer
Division of Surgical Oncology, National Cancer Centre, Singapore, Singapore
Anne W. M. Lee, MD
Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China
Everett E. Vokes, MD
Department of Medicine and Cancer Research Center, The University of Chicago Medical Center, Chicago, Illinois, USA
Joseph Tien Seng Wee
Division of Radiation Oncology, National Cancer Centre Singapore, Duke-NUS Graduate Medical School, Singapore
Christophe Le Tourneau, MD, PhD
INSERM U900 Research Unit, Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris, France
Editorial Board (Melanoma)
Frank Stephen Hodi, Jr, MD
Harvard Medical School, Dana-Farber Cancer Institute, Melanoma Disease Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA
Dirk Schadendorf, MD
Department of Dermatology, University Hospital Essen, Essen, Germany
Editorial Board (Neuro-Oncology)
Manmeet Ahluwalia, MD, FACP
Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic Cleveland, Ohio, USA
Jon Glass, MD
Departments of Neurology and Neurological Surgery; Vickie and Jack Farber Institute for Neuroscience and Sidney Kimmel Cancer Center; Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Young Zoon Kim, MD, PhD
Neuro-Oncology Division, and Neurosurgical Department, Sungkyunkwan University School of Medicine, Samsung Changwon Hospital, Changwon, South Korea
Simon S. Lo, MD, FACR, FASTRO
Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA
Rimas V. Lukas
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Shearwood McClelland III, MD
Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Joshua D. Palmer, MD
Assistant Professor, Department of Radiation Oncology, Assistant Professor of Neurosurgery, The James Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA
Michael Weller, MD
Department of Neurology, University Hospital Zurich, Zurich, Switzerland
Wolfgang Wick
Neurology Clinic and Neurooncology Program at the National Center for Tumor Disease, University Hospital Heidelberg, Heidelberg, Germany
Editorial Board (Neuroendocrine Neoplasm)
Kjell ÖBERG, MD, PhD
Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden
Editorial Board (Thoracic Oncology)
Andrea Camerini, MD, PhD
Medical Oncology, Versilia Hospital and Istituto Toscano Tumori, Lido di Camaiore, Italy
Takefumi Komiya, MD, PhD
Medical Oncologist (Thoracic)
Parkview Cancer Institute, Parkview Health
Volunteer Clinical Assistant Professor, Indiana University School of Medicine, USA
Alexander V. Louie
Sunnybrook Health Science Centre, Department of Radiation Oncology, University of Toronto, Canada
Daniela Molena, MD
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Editorial Board (Urologic Oncology)
Douglas McNeel, MD, PhD
UW Carbone Cancer Center, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA
Richard J. Ablin, PhD
Department of Pathology, The University of Arizona, Tucson, AZ, USA
Editorial Board (Statistics in Oncology Clinical Trials)
James J. Dignam, PhD
Professor of Biostatistics, Department of Public Health Sciences, The University of Chicago Biological Sciences, Illinois, USA
Qian Shi, PhD
Professor of Biostatistics and Oncology, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA
Xiaofei Wang, PhD
Xiaofei Wang, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA
Jun (Vivien) Yin, PhD
Cancer Center Statistics, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA
Editorial Board (Translation Cancer Research)
Lydia W. T. Cheung
School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
O. Hans Iwenofu
Department of Pathology & Laboratory Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA
H. Kim Lyerly, MD
Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina, USA
Paul Waring
Centre for Translational Pathology, Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia; Department of Surgery, University of Melbourne, Parkville, Victoria 3010, Australia.
Editorial Board (Gynecologic Oncology)
Kevin V. Albuquerque, MBBS, M.S., F.R.C.S., DABR
Harold C Simmons Comprehensive Cancer Center, Department of Radiation Oncology, U.T. Southwestern Medical Center, Dallas, Texas, USA
Don S. Dizon
Division of Medical Oncology, Department of Medicine, Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI, USA
Peixin Dong, MD, PhD
Department of Obstetrics and Gynecology, Hokkaido University, Sapporo, Japan
Christina Fotopoulou
Department of Gynaecologic Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Jitti Hanprasertpong, MD
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
Antonio Simone Laganà
Medical Doctor at the Department of Obstetrics and Gynecology, “Filippo Del Ponte” Hospital, University of Insubria, Varese, Italy
Saul E. Rivkin
Swedish Cancert Institute; Marsha Rivkin Center for Ovarian Cancer Research, Seattle, Washington, USA.
Denis Querleu
Institut Bergonié Cancer Center, Bordeaux, France
Flavio Rizzolio, PhD
Natl Canc Inst CRO IRCSS, Dept Translat Res, Aviano, Italy
Bo R. Rueda, PhD
Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology. Massachusetts General Hospital, Boston, Massachusetts, USA
Yong-Sang Song, MD, PhD
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
Editorial Board (Interventional Oncology)
David C. Madoff
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
Editorial Board (Sarcoma)
Kenneth Cardona, MD, FACS
Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
Rick L. Haas
Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, The Leiden University Medical Center, Leiden, The Netherlands
Raphael E. Pollock, MD, PhD
The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
William W. Tseng, MD
University of Southern California, Keck School of Medicine, Los Angeles, California, USA
Managing Editors
Grace S. Li
Editorial Office, Chinese Clinical Oncology
Eunice X. Xu
Editorial Office, Chinese Clinical Oncology
Language Editors
Jeremy Dean Chapnick
Chief Language Editor, AME Hong Kong office; United States University Carthage College, Wisconsin, USA (Sept. 2012 to May 2016)
John Ayric Gray
Chief Language Editor, AME Hong Kong office; University of Toronto, Toronto, Canada (Sept. 2004-June 2009)
Academic Editors
CCO appreciates the support from a strong team of academic editors who help to identify newly published research articles which have great clinical significance and as well as recommend international experts in the field to comment on the new publications. The list of the academic editors is available here: http://www.theaber.com/academicEditorList.
